Enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: a randomized crossover trial
Open Access
- 24 November 2005
- journal article
- research article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 3 (12) , 2649-2655
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Terms and ConditionsCirculation, 2004
- Effect of clopidogrel pretreatment on inflammatory marker expression in patients undergoing percutaneous coronary interventionThe American Journal of Cardiology, 2004
- Predictive Value of Elevated White Blood Cell Count in Patients With Preexisting Coronary Heart DiseaseArchives of internal medicine (1960), 2004
- Functional and Biochemical Evaluation of Platelet Aspirin Resistance After Coronary Artery Bypass SurgeryCirculation, 2003
- Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary InterventionJAMA, 2002
- Platelets in atherothrombosisNature Medicine, 2002
- Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment ElevationNew England Journal of Medicine, 2001
- Thienopyridines or Aspirin to Prevent Stroke and Other Serious Vascular Events in Patients at High Risk of Vascular Disease?Stroke, 2000
- Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort studyBMJ, 1996
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 1996